Published 28 Feb 2025
The CADIFA (Active Pharmaceutical Ingredient Dossier Adequacy Letter) is an administrative instrument that attests to the compliance of the DIFA (Active Pharmaceutical Ingredient Dossier).
It guarantees the quality of the API according to some specified tests. The CADIFA is a necessary document for the registration of an IFA, for all companies that want to sell pharmaceutical products in Brazil. Almost two years ago we got our first CADIFA and now there are already five registered. More approvals are expected in 2025. For questions or more information, please feel free to contact us at api@nl.aspenpharma.com
